Clinuvel Pharmaceuticals Ltd. (CUVL)
4.94
-0.09
(-1.79%)
USD |
NASDAQ |
Oct 23, 16:00
4.94
0.00 (0.00%)
After-Hours: 20:00
Clinuvel Pharmaceuticals Price : 4.94 for Oct. 23, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | 5.00 | 5.02 | 4.93 | 4.94 | 4712.00 |
| Oct 22, 2026 | 5.15 | 5.40 | 4.95 | 5.03 | 23846.00 |
| Oct 21, 2026 | 5.12 | 5.12 | 5.12 | 5.12 | 693.00 |
| Oct 20, 2026 | 5.24 | 5.24 | 5.13 | 5.19 | 3103.00 |
| Oct 19, 2026 | 5.24 | 5.395 | 5.24 | 5.24 | 6961.00 |
| Oct 16, 2026 | 5.38 | 5.38 | 5.18 | 5.235 | 3236.00 |
| Oct 15, 2026 | 4.91 | 5.23 | 4.91 | 5.06 | 3398.00 |
| Oct 14, 2026 | 5.38 | 5.387 | 5.30 | 5.30 | 3593.00 |
| Oct 13, 2026 | 5.60 | 5.60 | 5.42 | 5.442 | 5029.00 |
| Oct 12, 2026 | 5.70 | 5.802 | 5.584 | 5.584 | 10529.00 |
| Oct 09, 2026 | 5.56 | 5.59 | 5.56 | 5.59 | 1622.00 |
| Oct 08, 2026 | 5.65 | 5.65 | 5.525 | 5.60 | 13753.00 |
| Oct 07, 2026 | 5.75 | 5.80 | 5.718 | 5.80 | 2195.00 |
| Oct 06, 2026 | 5.650 | 5.74 | 5.650 | 5.67 | 3547.00 |
| Oct 05, 2026 | 5.72 | 5.74 | 5.65 | 5.74 | 9623.00 |
| Oct 02, 2026 | 6.03 | 6.03 | 6.03 | 6.03 | 981.00 |
| Oct 01, 2026 | 5.57 | 5.74 | 5.57 | 5.66 | 10432.00 |
| Sep 30, 2026 | 5.907 | 6.00 | 5.90 | 5.96 | 13138.00 |
| Sep 29, 2026 | 5.76 | 5.87 | 5.76 | 5.87 | 2206.00 |
| Sep 28, 2026 | 5.66 | 5.80 | 5.63 | 5.75 | 8705.00 |
| Sep 25, 2026 | 5.82 | 5.82 | 5.60 | 5.63 | 13338.00 |
| Sep 24, 2026 | 5.88 | 5.88 | 5.78 | 5.78 | 2354.00 |
| Sep 23, 2026 | 5.87 | 5.87 | 5.755 | 5.79 | 8326.00 |
| Sep 22, 2026 | 5.80 | 5.90 | 5.79 | 5.80 | 4592.00 |
| Sep 21, 2026 | 5.85 | 5.90 | 5.70 | 5.80 | 39258.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Alterity Therapeutics Ltd. | 2.09 |
| Kazia Therapeutics Ltd. | 7.81 |
| Algorae Pharmaceuticals Ltd. | 0.0096 |
| Immuron Ltd. | 0.9535 |
| Amplia Therapeutics Ltd. | 0.055 |
Price Related Metrics
| PE Ratio | 10.74 |
| PS Ratio | 3.895 |
| PEG Ratio | 35.18 |
| Price to Free Cash Flow | 10.10 |
| Earnings Yield | 9.31% |
| Market Cap | 249.11M |
| PEGY Ratio | 10.43 |
| Operating PE Ratio | 8.961 |
| Normalized PE Ratio | 10.74 |